Peer-reviewed Publications 2026

1. Cancer burden and risk factors among women with HIV: a multi-regional study from the D:A:D and RESPOND cohort collaborations. Han WM, Neesgaard B, Knappik M, Cavassini M, Abela IA, Timiryasova A, Greenberg L, Martin C, Mussini C, Wit F, Sabin C, Castagna A, Abutidze A, El-Sadr W, Bonnet F, Sarcletti M, Carlander C, Hachfeld A, Weis N, Vannappagari V, Rogatto FP, Young LA, Hosein SR, Ryom L, Petoumenos K; D:A:D; RESPOND collaborations.
   eClinical Medicine. 2026 Jan 9;91:103739.  Abstract

2. Association of leukocyte count with death in people with HIV: A longitudinal study over 24 years. Klein Z, Meyer SC, Schoepf IC, Weber M, Thorball CW, Ryom L, Kootstra NA, Reiss P, Braun DL, Thurnheer MC, Marzolini C, Kahlert CR, Bernasconi E, Cavassini M, Marinosci A, Fellay J, Kouyos RD, Günthard HF, Ledergerber B, Tarr PE; and the Swiss HIV Cohort Study.
   PLoS One. 2026;21(1):e0340678.  Abstract

3. Reply to: HIV-TB risk factor assessment in Europe: methodological considerations and clinical implications. Kraef C, Ryom L, Kirk O; writing group and the RESPOND study group.
   Eur Respir J. 2026;67(3):2502523.  Abstract

4. Barriers and Opportunities to Include Underrepresented Population Groups in Vaccine Trials: Cross-Sectional, Observational, Online Survey Study From the VACCELERATE Research Network. Tanriover MD, Poulimeneas D, Tsopela GC, Kopsidas I, Argyropoulos C, Di Marzo R, Valdenmaiier O, Jakobsen SF, Valle Simon P, Carcas-Sansuan AJ, Olesen OF, Cornely OA, Pana ZD, Zaoutis T, Akova M.
   JMIR Public Health Surveill. 2026;12:e89025.  Abstract

5. An overview of consent requirements for HIV and viral hepatitis B and C testing in Europe. Stengaard AR, Sullivan AK, Simões D, Diderichsen J, Raben D, Rockstroh JK; EuroTEST Steering Committee.
   HIV Med. 2026. Epub ahead of print.   Abstract

6. Trends in AIDS-defining illnesses among people living with HIV in clinical care in Europe: results from the EuroSIDA multicentre cohort study (2003-24). Bannister WP, Reekie J, Peters L, Oprea C, Matulionytė R, Scheerder MA, Kryshchuk A, Rasmussen LD, Burns F, Zilmer K, Jablonowska E, Boesecke C, Zagalo A, Martinez E, Stoeckle M, Szlávik J, Cetkovic JT, Adamis G, Kowalska JD, Podlekareva D; EuroSIDA Study Group.
   Lancet HIV. 2026 May:S2352-3018(26)00052-4. Epub ahead of print.  Abstract

7. Mortality Attributable to Hepatitis B and C in Italy, Romania, and Spain, 2022 Estimates. Korotych O, Thygesen HH, Mårdh O, Reyes-Urueña J, Marrone G, Rockstroh J, Jakobsen ML, de Martel C, Kondili LA, Quaranta MG, Mattioli B, Rosato S, Rendina M, De Feudis A, Cossiga V, Albano S, Morisco F, Viganò M, Loglio A, Fagiuoli S, Calvaruso V, Celsa C, Longobardi F, Coppola R, Russo FP, Battistella S, Coppola N, Sagnelli C, Coco B, Brunetto MR, Popovici O, Janță D, Calomfirescu C, Gheorghe LS, Ghioca M, Ester C, Chitul M, Cerban R, Trifan A, Huiban L, Muzica C, Popescu A, Sirli R, Nica C, Popa A, Ferret MB, Vargas-Accarino E, Díaz A, Méndez CF, Morano L, Alonso S, Ahumada A, Cañizares RB, Raben D, Duffell E.
   Liver Int. 2026;46(7):e70753.  Abstract

8. In press: CD4 Cell Count Trends After the Common Cancers in People With HIV: A Multicohort Collaboration Timiryasova A, Greenberg L, Domingo P, Tarr PE, Egle A, Martin C, Mussini C, Wit F, Cingolani A, Lehmann C, Castagna A, Petoumenos K, Sabin CA, Borges A, El-Sadr W, Lundgren J, Hosein S, Carlander C, Amstutz A, Grabmeier-Pfistershammer K, Garges H, Marongiu A, Young LA, Peters L, Ryom L; for the D:A:D and RESPOND Study Groups
   AIDS. 2026 

9. Association of a polygenic risk score with low trauma fractures in people with HIV - The swiss HIV cohort study. Strickler C, Thorball CW, Schoepf IC, Schwenke J, Hasse B, Ryom L, Thurnheer MC, Fux C, Kahlert CR, Bernasconi E, Calmy A, Lamy O, Günthard HF, Ledergerber B, Fellay J, Tarr PE; Swiss HIV Cohort Study.
   PLoS One. 2026;21(2):e0342748.  Abstract

10. Unified Machine Learning Model for Relapse Prediction in Clinical Stage I Testicular Cancer. Wagner T, Marandi RZ, Lauritsen J, Murray DD, Bandak M, Grønkær Toft B, Berney D, Daugaard G. A
    Andrology. 2026:e70195. Epub ahead of print.  Abstract

11. Burden of respiratory syncytial virus and influenza in adults - a Danish nationwide cohort study. Fonseca MJ, Bratković S, Pedersen M, Kany M, Pliakas T, Reeves R, Marijam A, Turriani E, Vestergaard Dich N, Çolak Y, Helleberg M.
    Clin Microbiol Infect. 2026;32(6):1006-1014.  Abstract

12. Comparing risk factors in severe COVID-19 using machine learning and non-machine learning methods: analysis from 2 international randomized controlled trials. Møller Jensen C, Zargari Marandi R, Moestrup KS, Mourad A, Mena Lora AJ, Sherman BT, Vock DM, Nordwall JA, Carson JM, Peiffer-Smadja N, Aggarwal NR, Naiman NE, Brown SM, Barrett TW, Hatlen T, Kjærgaard VS, Chang W, Sydes MR, Lundgren J, Jensen TO; STRIVE Network and ITAC and TICO Study Groups.
    JAMIA Open. 2026;9(3):ooag079.  Abstract

13. CYP2B6 polymorphisms and suicidal behaviour in people living with HIV treated with efavirenz-containing combination antiretroviral therapy: a global case-control study. Arenas-Pinto A, Nordwall J, Carey D, Fletcher CV, Badley AD, Thompson G, Reilly C, Safo SE, Grund B, Lundgren J.
    Front Pharmacol. 2026;17:1734919.  Abstract

14. Early chest x-ray severity assessed by the MBrixia score is associated with mortality in hospitalized patients with COVID-19 pneumonia. Jensen CM, Marandi RZ, Costa JC, Zetner D, Berger SMS, Niemann CU, Ostrowski SR, Reekie J, Holten B, Kalhauge A, Ledergerber B, Lundgren J, Helleberg M, Moestrup KS.
    Sci Rep. 2026;16(1):8309.  Abstract

15. Frequency of viral monitoring to detect cytomegalovirus infection and prevent disease in solid organ transplant recipients: An international, multicenter cohort study. Dahl AL, Manuel O, Koller M, Thygesen HH, Perch M, Rossing K, Schultz N, Sorensen SS, Schønning K, Lundgren J, Mueller NJ, Helleberg M.
    Am J Transplant. 2026;26(6):1482-1490.  Abstract

16. Hepatic cystic echinococcosis in a low-endemic region, Denmark. Naustdal CN, Helleberg M, Fallentin E, Madsen LG.
    IDCases. 2026;43:e02493.  Abstract

17. Immunogenicity of SARS-CoV-2 primary vaccination and boosters in patients with immune-mediated inflammatory diseases: Impact of immunosuppressive therapy. Larsen FD, Juhl AK, Dietz LL, Nielsen H, Stærke NB, Johansen IS, Wiese L, Benfield T, Bodilsen J, Klastrup V, Lindvig SO, Rasmussen LD, Knudsen LS, Tolstrup M, Østergaard LJ, Lundgren J, Søgaard OS, Larsen CS; ENFORCE Study Group.
    Vaccine. 2026;73:128155.  Abstract

18. Impact of a multi-disciplinary antimicrobial stewardship programme on piperacillin-tazobactam use at a Danish university hospital: a before-and-after interventional study. Holler JG, Printzlau P, Jensen TO, Rezahosseini O, Kraef C, Harboe ZB, Lindegaard B, Kolte L, Pedersen TI, Hansen DS, Søborg C.
    J Hosp Infect. 2026;170:81-91.  Abstract

19. Incidence of respiratory syncytial virus and influenza: A Danish nationwide cohort study. Fonseca MJ, Bratković S, Pedersen M, Kany M, Pliakas T, Reeves R, Marijam A, Turriani E, Vestergaard Dich N, Çolak Y, Helleberg M.
    Hum Vaccin Immunother. 2026;22(1):2638638.  Abstract

20. Investigating the Impact of Host Genetics on the Risk of Disease Progression in Individuals With Influenza. Mørup SB, Milojevic M, Shahri SMT, Sherman BT, Chang W, Lynfield R, Helleberg M, Skeans M, Østergaard L, Borgwardt L, Gerry N, Losso M, Baillie K, Davey R, Dwyer DE, Phetsouphanh C, Papastamopoulos V, Novak RM, Murray DD, Reekie J, Lundgren JD, Lane HC, Reilly C; INSIGHT FLU 002 Plus and FLU 003 Plus Study Groups.
    Immun Inflamm Dis. 2026;14(3):e70394.  Abstract

21. Mycobacterium tuberculosis in HIV co-infection: a growing concern in Europe? Kraef C, Kirk O.
    Curr Opin HIV AIDS. 2026;21(2):166-171.  Abstract

22. Prognostic Value of Lung Injury Biomarkers in Patients Hospitalized With COVID-19 Without Respiratory Failure at Admission. Wilson JG, Grandits GA, Grund B, Mistry SS, Leroux C, Ringor A, Aggarwal NR, Murray DD, Barkauskas CE, Brown SM, Higgs E, Shaw-Saliba K, Rupert A, Kan VL, Beitler JR, Awan O, Sturgill JL, Dawood H, Kalil AC, Kalomenidis I, Duggal A, Sasson SC, Ho MQ, Nguyen HH, Lundgren JD, Ginde AA, Self WH, Lane HC, Matthay MA, Rogers AJ; Strategies and Treatments for Respiratory Infections and Viral Emergencies (STRIVE) Network and Therapeutics for Inpatients with COVID-19 (TICO) Trial Study Group.
    Crit Care Med. 2026. Epub ahead of print.  Abstract

23. Severe Hospitalization-Requiring Viral Infection With Influenza or COVID-19: Metabolic Pathway Analysis. Rasmussen KK, Bannister W, Itenov T, Skeans M, Pett SL, Wendt C, Kunisaki KM, Matthews G, Jordan A, Ulrik CS, Lapperre T, Bojesen RD, Bodtger U, Ilett EE, Benfield T, Sivapalan P, Murray DD, Jensen JS.
    Open Forum Infect Dis. 2026;13(6):ofag316.  Abstract

24. Use of selective decontamination of the digestive tract in burn patients: A European survey. Tsuchiya EA, Krag M, Møller MH, Vestergaard MR, Haase N, Helleberg M, Holmgaard R, Heiberg J.
    Burns. 2026;52(1):107774.  Abstract

In Press